Alpha-fetoprotein (AFP) remains the most widely used serum biomarker in HCC surveillance; however, its sensitivity for early-stage disease is limited, and levels can be elevated in chronic hepatitis or cirrhosis. This evidence concerns the gene AFP and Cirrhosis.